Evogene OverviewEvogene EBIT
EBIT (Earnings Before Interest and Taxes) analysis for EVGN.
Quarterly EBIT
-$11.50M
↓ 355.33% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$21.65M
↓ 26.88% YoY
Trailing 12 months ending Mar 31, 2026
Evogene OverviewEBIT (Earnings Before Interest and Taxes) analysis for EVGN.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026